EMV Capital backed Wanda Health announces strategic partnership with COPD Foundation [Video]

EMV Capital (AIM:EMVC) portfolio company Wanda Health’s CEO Tom smith joined Steve Darling from Proactive to share news the company has announced a strategic partnership with the COPD Foundation, a prominent nonprofit dedicated to supporting individuals affected by chronic lung diseases, including Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis, and NTM lung disease. COPD impacts over 30 million Americans and ranks as the third leading cause of death globally.

Smith shared with Steve Darling from Proactive that this collaboration will grant Wanda Health access to some of the world’s top experts in respiratory health. By tapping into their knowledge, Wanda aims to refine its innovative platform and proprietary AI and Machine Learning (ML) capabilities, enhancing its ability to deliver early detection and intervention for patients with acute and chronic conditions.

The partnership also includes marketing opportunities, such as space in a peer-reviewed medical journal, to reach broader healthcare audiences. Wanda’s platform empowers healthcare providers …